Imexpharm

Imexpharm Current Liabilities

The Current Liabilities of Imexpharm (IMP.VN) as of Oct 26, 2026 is 177.11 B VND. In the previous year, Current Liabilities was 148.68 B VND — a change of 19.12% (higher).

Current Liabilities

177.11 BVND

YoY

19.12%

Last updated:

Current Liabilities of Imexpharm is 2025 177.11 B VND. Current Liabilities of Imexpharm was 2024 148.68 B VND. It decreases by 19.12% higher compared to the previous year.

The Imexpharm Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
236.48 B VND
Jan 1, 2019
221.87 B VND
Jan 1, 2020
209.84 B VND
Jan 1, 2021
186.71 B VND
Jan 1, 2022
221.02 B VND
Jan 1, 2023
209.96 B VND
Jan 1, 2024
148.68 B VND
Jan 1, 2025
177.11 B VND
The Imexpharm Current Liabilities history
YEARCurrent LiabilitiesYoY
177.11 BVND+19.12%
148.68 BVND-29.18%
209.96 BVND-5.01%
221.02 BVND+18.38%
186.71 BVND-11.02%
209.84 BVND-5.42%
221.87 BVND-6.18%
236.48 BVND-31.23%
343.86 BVND+73.55%
198.13 BVND+26.65%
156.44 BVND-21.91%
200.33 BVND+67.38%
119.68 BVND-11.18%
134.75 BVND+15.52%
116.64 BVND-27.11%
160.04 BVND-9.78%
177.37 BVND+125.53%
78.65 BVND+12.08%
70.17 BVND+0.23%
70.01 BVND-52.02%
145.92 BVND-1.29%
147.83 BVND-2.03%
150.89 BVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

Current Liabilities of Imexpharm is 177.11 B VND in 2025.

Current Liabilities of Imexpharm changed from 148.68 B VND to 177.11 B VND, representing a 19.12% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Imexpharm since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Imexpharm historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Imexpharm

All Key Metrics — Imexpharm